{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:48:54Z","timestamp":1769107734996,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":116,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.idcr.2021.e01143","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T13:08:51Z","timestamp":1619788131000},"page":"e01143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Guillain-Barr\u00e9 syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8286-992X","authenticated-orcid":false,"given":"Osakpolor","family":"Ogbebor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshit","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaw","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Bhanot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2021.e01143_bib0005","unstructured":"COVID-19 Vaccines. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/covid-19-vaccines. [Accessed 22 April 2021]."},{"key":"10.1016\/j.idcr.2021.e01143_bib0010","unstructured":"VAERS. Vaccine Adverse Event Reporting System. https:\/\/vaers.hhs.gov\/about.html [Accessed 22 April 2021]."},{"key":"10.1016\/j.idcr.2021.e01143_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.idcr.2021.e01143_bib0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.idcr.2021.e01143_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.idcr.2021.e01143_bib0030","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta- analysis","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.idcr.2021.e01143_bib0035","unstructured":"CDC. Guillain-Barr\u00e9 Syndrome and Vaccines. https:\/\/www.cdc.gov\/vaccinesafety\/concerns\/guillain-barre-syndrome.html [Accessed 23 April 2021]."},{"key":"10.1016\/j.idcr.2021.e01143_bib0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10072-020-04553-9","article-title":"Is Guillain-Barr\u00e8 syndrome triggered by SARS-CoV-2? Case report and literature review","volume":"42","author":"Agosti","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.idcr.2021.e01143_bib0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/brain\/awaa444","article-title":"COVID-19 vaccine and Guillain-Barr\u00e9 syndrome: let\u2019s not leap to associations","volume":"144","author":"Lunn","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.idcr.2021.e01143_bib0050","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Keddie","year":"2021","journal-title":"Brain"},{"issue":"April (6)","key":"10.1016\/j.idcr.2021.e01143_bib0055","article-title":"Guillain- Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality","author":"M\u00e1rquez Loza","year":"2021","journal-title":"Neurology"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250921000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250921000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:05:00Z","timestamp":1761998700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250921000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":11,"alternative-id":["S2214250921000998"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2021.e01143","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain-Barr\u00e9 syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2021.e01143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01143"}}